Yibo Gao Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

4/2022	Sintilimab for the treatment of non-small cell lung cancer.
1/2022	Choline Kinase Alpha2 Promotes Lipid Droplet Lipolysis in Non-Small-Cell Lung Carcinoma.
1/2021	Safety and Efficacy of Neoadjuvant Immune Checkpoint Inhibitor Therapy in Patients with Resectable Non-small-Cell Lung Cancer: A Systematic Review.
1/2021	Prognostic Impact of PCK1 Protein Kinase Activity-Dependent Nuclear SREBP1 Activation in Non-Small-Cell Lung Carcinoma.
5/2020	Utility of isocitrate dehydrogenase 1 as a serum protein biomarker for the early detection of non-small-cell lung cancer: A multicenter in vitro diagnostic clinical trial.
1/2019	Knockdown of KLF5 promotes cisplatin-induced cell apoptosis via regulating DNA damage checkpoint proteins in non-small cell lung cancer.
1/2019	Prognostic Impact of Metabolism Reprogramming Markers Acetyl-CoA Synthetase 2 Phosphorylation and Ketohexokinase-A Expression in Non-Small-Cell Lung Carcinoma.
1/2018	Primary and acquired EGFR T790M-mutant NSCLC patients identified by routine mutation testing show different characteristics but may both respond to osimertinib treatment.
11/2017	Postoperative survival of EGFR-TKI-targeted therapy in non-small cell lung cancer patients with EGFR 19 or 21 mutations: a retrospective study.
12/2013	Folate receptor-positive circulating tumor cells as a novel diagnostic biomarker in non-small cell lung cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yibo Gao Research Topics

Disease

39	Neoplasms (Cancer) 04/2022 - 02/2012
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 02/2012
10	Esophageal Squamous Cell Carcinoma 01/2022 - 03/2013
7	Adenocarcinoma of Lung 04/2022 - 09/2013
7	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2017
6	Carcinogenesis 01/2021 - 01/2015
5	Lung Neoplasms (Lung Cancer) 01/2022 - 03/2014
3	Neuralgia (Stump Neuralgia) 12/2021 - 01/2018
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2018
2	Breast Neoplasms (Breast Cancer) 01/2022 - 10/2019
2	Placenta Diseases (Placenta Disorder) 01/2022 - 10/2021
2	Carcinoma (Carcinomatosis) 01/2021 - 12/2019
2	Melanoma (Melanoma, Malignant) 10/2016 - 11/2015
1	Hepatocellular Carcinoma (Hepatoma) 04/2022
1	Hodgkin Disease (Hodgkin's Disease) 04/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 11/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Neutropenia 01/2021
1	Infections 01/2021
1	Adenoid Cystic Carcinoma (Cylindroma) 01/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Fatigue 01/2021
1	Deglutition Disorders (Dysphagia) 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Amnesia (Dissociative Amnesia) 01/2021
1	Postoperative Pain 01/2019
1	Residual Neoplasm 01/2019

Drug/Important Bio-Agent (IBA)

14	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2012
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2012
5	LigandsIBA 01/2020 - 12/2013
4	RNA (Ribonucleic Acid)IBA 04/2022 - 05/2012
4	MicroRNAs (MicroRNA)IBA 02/2022 - 05/2012
4	Pharmaceutical PreparationsIBA 01/2021 - 03/2013
3	Biological ProductsIBA 04/2022 - 01/2018
3	Messenger RNA (mRNA)IBA 01/2021 - 08/2017
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2014
3	Protein Kinases (Protein Kinase)IBA 01/2021 - 02/2012
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 05/2020 - 02/2012
2	B7-H1 AntigenIBA 04/2022 - 01/2021
2	KisspeptinsIBA 01/2022 - 10/2021
2	Lipase (Acid Lipase)FDA Link 01/2022 - 01/2021
2	CollagenIBA 01/2022 - 01/2017
2	Matrix Metalloproteinases (MMPs)IBA 10/2021 - 01/2017
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2021
2	IronIBA 01/2021 - 01/2021
2	EnzymesIBA 01/2021 - 01/2020
2	Tumor Biomarkers (Tumor Markers)IBA 05/2012 - 02/2012
1	anlotinibIBA 04/2022
1	sintilimabIBA 04/2022
1	Docetaxel (Taxotere)FDA Link 04/2022
1	Monoclonal AntibodiesIBA 04/2022
1	PlatinumIBA 04/2022
1	Choline KinaseIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Keratins (Keratin)IBA 01/2022
1	Glutamine (L-Glutamine)FDA Link 01/2022
1	Amino Acids FDA Link 01/2022
1	ChemokinesIBA 12/2021
1	RoscovitineIBA 12/2021
1	MK 2206IBA 12/2021
1	Vorinostat FDA Link 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	N-methyladenosineIBA 01/2021
1	ChromatinIBA 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	Sterol Regulatory Element Binding Protein 1IBA 01/2021
1	CateninsIBA 01/2021
1	6-methyladenineIBA 01/2021
1	Morphine (MS Contin)FDA LinkGeneric 01/2021
1	Polygalacturonase (Pectinase)IBA 01/2021
1	PhosphoenolpyruvateIBA 01/2021
1	MethyltransferasesIBA 01/2021
1	Singlet OxygenIBA 09/2020
1	Blood Proteins (Serum Proteins)IBA 05/2020
1	Cyclin D1IBA 01/2020
1	Monoacylglycerol LipasesIBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	Cyclin B1IBA 01/2020
1	AntibodiesIBA 10/2019
1	melamineIBA 06/2019
1	Urea (Carbamide)FDA LinkGeneric 06/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	Hydromorphone (Dilaudid)FDA LinkGeneric 01/2019
1	Analgesics (Analgesic Drugs)IBA 01/2019
1	ketohexokinaseIBA 01/2019
1	Acetate-CoA Ligase (Acetyl CoA Synthetase)IBA 01/2019
1	Apolipoproteins E (ApoE)IBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018

Therapy/Procedure

10	Immunotherapy 04/2022 - 03/2018
10	Therapeutics 01/2022 - 01/2013
4	Radiotherapy 04/2022 - 01/2019
3	Drug Therapy (Chemotherapy) 04/2022 - 01/2015
2	Analgesia 01/2021 - 01/2021
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2013 - 01/2012
1	General Anesthesia 01/2021
1	Precision Medicine 01/2021
1	Esophagectomy 01/2019
1	Adjuvant Radiotherapy 01/2019